Provided by Tiger Fintech (Singapore) Pte. Ltd.

X4 Pharmaceuticals Inc

0.2946
-0.0191-6.09%
Volume:2.69M
Turnover:815.26K
Market Cap:50.24M
PE:-3.43
High:0.3233
Open:0.3203
Low:0.2900
Close:0.3137
Loading ...

XFOR: Positive Results for Phase 2 Trial of Mavorixafor in Chronic Neutropenia…

Zacks Small Cap Research
·
14 Nov 2024

X4 Pharmaceuticals Inc (XFOR) Q3 2024 Earnings Call Highlights: Strategic Engagement and ...

GuruFocus.com
·
14 Nov 2024

X4 Pharmaceuticals Inc : Piper Sandler Cuts Target Price to $2 From $3

THOMSON REUTERS
·
14 Nov 2024

X4 Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
13 Nov 2024

BRIEF-X4 Pharmaceuticals Reports Q3 2024 Financial Results And Provides Corporate Update

Reuters
·
13 Nov 2024

BRIEF-X4 Pharmaceuticals reports positive results from completed six-month phase 2 trial of Mavorixafor

Reuters
·
13 Nov 2024

X4 Pharmaceuticals: Q3 Earnings Snapshot

Associated Press Finance
·
13 Nov 2024

X4 Pharmaceuticals Q3 2024 GAAP EPS $(0.18) Misses $(0.17) Estimate, Sales $560.00K Miss $1.69M Estimate

Benzinga
·
13 Nov 2024

X4 Pharmaceuticals Q3 Operating Expenses USD 35.06 Million

THOMSON REUTERS
·
13 Nov 2024

X4 Pharmaceuticals Q3 EPS USD -0.18 VS. Ibes Estimate USD -0.17

THOMSON REUTERS
·
13 Nov 2024

X4 Pharmaceuticals: Co Had $135.8 Mln in Cash, Cash Equivalents, Restricted Cash, & Short-Term Marketable Securities as of Sept 30, 2024

THOMSON REUTERS
·
13 Nov 2024

X4 Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
13 Nov 2024

X4 Pharmaceuticals Inc - Mavorixafor Well Tolerated With No Serious Adverse Events

THOMSON REUTERS
·
13 Nov 2024

X4 Pharmaceuticals- Mavorixafor Durably Elevates Mean Absolute Neutrophil Counts

THOMSON REUTERS
·
13 Nov 2024

X4 Pharmaceuticals Inc - Mavorixafor Enables Reductions in G-Csf Dosing While Maintaining Anc

THOMSON REUTERS
·
13 Nov 2024

X4 Pharmaceuticals Announces Positive Results From Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (Cn)

THOMSON REUTERS
·
13 Nov 2024